Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Commentary/Perspective

Home / Publications / Pain Research Forum / Papers of the Week / Commentary/Perspective
Share this

Editorial: Insights in musculoskeletal pain: 2022.

Learn More >

Author Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.

Learn More >

Editors’ Note: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.

Learn More >

Reader Response: Microembolism and Other Links Between Migraine and Stroke: Clinical and Pathophysiologic Update.

Learn More >

Advances with the discovery and development of novel Sigma 1 receptor antagonists for the management of pain.

Interest in sigma-1 receptors (S1Rs) has significantly increased in the last 25 years and more recently for their role in pain modulation. S1Rs are novel chaperone proteins that modulate several […]

Learn More >

Rimegepant for migraine: acute efficacy beyond the USA.

Learn More >

The increasing role of electronic media in headache.

Most individuals with access to the internet use social media platforms. These platforms represent an excellent opportunity to disseminate knowledge about management and treatment to the benefit of patients. The […]

Learn More >

A perspective on a precision approach to pain in cancer; moving beyond opioid therapy.

Cancer-related pain is primarily treated with opioids which while effective can add significant patient burden due to side effects, associated stigma, and timely access. The purpose of this perspective discussion […]

Learn More >

Upadacitinib for moderate to severe atopic dermatitis.

Atopic dermatitis is an inflammatory skin disease, the prevalence of which has increased in the last decade. It affects all age groups, with adult involvement being a major focus of interest […]

Learn More >

Chronic pain: try new routes to more tailored treatments.

Learn More >

Search